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Abstract
Conditional gene targeting using the Cre-loxp system is a well established technique in numerous in vitro and in vivo
systems. Ligand regulated forms of Cre have been increasingly used in these applications in order to gain temporal and
spatial control over conditional targeting. The tamoxifen-regulated Cre variant mer-Cre-mer (mCrem) is widely utilized
because of its reputation for tight regulation in the absence of its tamoxifen ligand. In the DT40 chicken B cell line, we
generated an mCrem-based reversible switch for conditional regulation of a transgene, and in contrast with previous work,
observed significant constitutive activity of mCrem. This prompted us to use our system for analysis of the parameters
governing tamoxifen-regulated mCrem recombination of a genomic target. We find that robust mCrem expression
correlates with a high level of tamoxifen-independent Cre activity, while clones expressing mCrem at the limit of western
blot detection exhibit extremely tight regulation. We also observe time and dose-dependent effects on mCrem activity
which suggest limitations on the use of conditional targeting approaches for applications which require tight temporal
coordination of Cre action within a cell population.
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Introduction
Conditional gene targeting allows for spatial and temporal
control of gene expression both in vitro and in vivo. Several systems
for conditional gene targeting exist, such as Flp/Frt, Cre/Loxp,
WC31-att, Mx-1/IFN-l?a, and Tet on/off [1,2]. One of the most
popular is the Cre-loxp system: a medline search for ‘‘Cre
recombinase’’ yields over 2000 publications, of which about 900
represent transgenic mice [3]. For this approach, a portion of a
gene is flanked by loxp sites, 34 base pair sequences consisting of
two 13 base inverted repeats flanking 8 non-palindromic bases.
Cre recombinase, nominally specific for these sites [4,5], either
excises or inverts flanked sequences depending on the relative
orientation of the two loxp sites, leading to changes in gene
function and/or expression. Historically, the popularity of the
Cre/loxp system derives from its apparent high fidelity, absence of
canonical recognition sites in the mammalian genome, and its high
efficiency of recombination as compared to other strategies [6,7].
Most of the work using the Cre-loxp system has been predicated
on the assumption that Cre, without Loxp targets, is largely
inactive in vertebrate cells. This assumption may have arisen in
part due to the lack of overt pathology in Cre expressing mice [8],
but given the ability of mammals to tolerate significant somatic cell
death this conclusion clearly requires validation. Several studies,
highlighted recently in two articles [3,9] have shown that use of the
Cre-loxp system in eukaryotic cells carries with it numerous
potential confounders such as variable efficiency of Cre expression
and/or recombination, variability in germline recombination, and,
contrary to the previously mentioned assumption, Cre mediated
toxicity [10–14].
In order to gain temporal and spatial control over conditional
gene targeting, ligand regulated forms of Cre are often utilized.
The tamoxifen-regulated Cre variants Cre-ER
T (Cre fused to a
mutated human estrogen receptor that binds tamoxifen or 4-
hydroxytamoxifen (OHT) but not endogenous estrogens, [11,15–
18]), and mer-Cre-mer (mCrem, which fuses Cre to two mutated
murine estrogen receptors responsive to tamoxifen/OHT but not
endogenous estrogens, much like Cre-ER
T above [19,20]) are
favored ligand-regulated Cres because of their reputation for tight
regulation in the absence of their tamoxifen/OHT ligands [20–
25]. Tamoxifen/OHT-regulatable Cre fusion proteins demon-
strate titratable toxicity, suggesting that Cre mediated toxicity is
dose- and exposure time-dependent. Over the course of these
titration studies it was observed that even in the absence of the
inducing ligand some cytotoxicity and/or gene expression could
be seen in several cell systems, including DT40 B lymphocytes
[11,19,26,27]. Additionally, it has been suggested that ligand
independent effects of inducible Cre may be altered by the
expression level of the Cre protein [26]. These results call the
efficiency of regulation of these Cre variants into question, and
suggest a need for a better understanding of how the parameters of
inducible Cre expression, Tamoxifen/OHT dose, and Tamoxi-
fen/OHT time of exposure interact to affect tight regulation of
ligand-induced Cre activity.
Our lab makes extensive use of DT40 B-cells as a model system
because they support facile gene targeting and are well validated
for studies of lymphocyte signaling and physiology [28–34]. To
effect conditional gene targeting in these cells, we have historically
used mCrem [35]. In the process of generating a Cre-mediated
reversible switching line with a fluorescent readout of Cre activity
PLoS ONE | www.plosone.org 1 September 2008 | Volume 3 | Issue 9 | e3264(Fig. 1A), we observed a high level of ligand-independent mCrem
activity. To understand how best to implement mCrem-based
conditional gene targeting, we have used this system to explore the
parameters governing tamoxifen-induced mCrem activity. The
results of our investigation show that the level of mCrem
expression correlates with Cre activity independent of OHT
treatment: high expression leads to abundant ligand-independent
activity, while low mCrem expression essentially abolishes activity.
Evaluation of time and dose effects in clones with variable
expression of mCrem suggests important limitations on the use of
mCrem for applications requiring temporally correlated Cre
activity within cell populations.
Results
DT40 B lymphocytes transfected with a reversible
switching construct and expressing mer-Cre-mer show
OHT-independent inversion of the floxed cassette
To better understand the function of the Nudix-type ADPR-
hydrolase NUDT9, our lab targeted this gene for deletion in
DT40 chicken B cells. Since we were unable to target both alleles
with classical knockout constructs, we reasoned that loss of
NUDT9 must be lethal in this cell type, and that therefore a
conditional knockout strategy would be required. We chose to
proceed with a reversible switching construct (Fig. 1A), in which a
chicken NUDT9 cDNA and an mCherry fluorescence reporter
were present in inverted orientation to one another. This
organization afforded us a fluorescent readout of Cre activity,
with activity in 100% of cells correlating to roughly 50% red
fluorescent cells [24]. Following selection of a clone that had stably
integrated the construct (Fig. 1B), we transfected this clone,
designated 27Flip, with a vector constitutively expressing mCrem
under the control of the CMV promoter.
Following transfection of the 27Flip cells with the mCrem
containing vector, stably expressing clones were identified and a
highly expressing clone, designated 27Flip/Cre20 was selected on
the basis of an mCrem western blot (Fig. 1C). Based on previous
work [20,24], it was anticipated that prior to treatment with OHT,
27Flip/Cre20 cells would show no mCherry fluorescence, similar
to the parental 27Flip line. However, the 27Flip/Cre20 clone
showed a sub population with robust red fluorescence (Fig. 1D)
prior to any tamoxifen exposure. Thus, we sought to identify the
cause of mCherry expression in these cells.
Sustained OHT-independent flipping of the floxed
cassette in 27Flip/Cre20 cells is a stable, ongoing process
We initially hypothesized that electroporation or other stressors
associated with transduction of DT40 cells with the mCrem
containing construct might lead to inefficient exclusion of mCrem
from the nucleus and subsequent Cre dependent switching of our
construct in affected cells. To test this hypothesis, we sorted mCherry
negative (‘‘white’’) and mCherry-positive (‘‘red’’) cells by flow
cytometry, and monitored the fluorescence of the separated
populations over time in the absence of OHT (Fig. 2). If mCrem
activity were a transient event associated with electroporation, these
sorted populations would be expected to remain stable over time.
However, we observed that white cells showed an outgrowth of red
cells and vice versa over a course of 7 weeks in culture. Interestingly,
red cells converted to white cells more rapidly, a phenomenon
potentially related to idiosyncratic differences in susceptibility of the
Figure 1. DT40 B lymphocytes transfected with a reversible switching construct and expressing mer-Cre-mer show 4-
hydroxytamoxifen independent Cre activity. A Schematic of the ‘‘Flip’’ construct. Exon 4 of NUDT9 was replaced with a CMV promoter, an
in-frame region (containing a NUDT9 cDNA and an inverted mCherry cDNA, each followed by a poly-A region) flanked by loxp sites, and a neomycin
selection cassette. Treatment of cells stably expressing the construct with 4-hydroxytamoxifen (OHT) should lead to reversible flipping of the floxed
region, as shown in the cartoon, and subsequent expression of mCherry red fluorescent protein in ,50% of the cells. B Stable integration of the Flip
construct was verified in clone #27 via genomic PCR. The positive control represents a different construct that could be amplified with the same
primer set. C Following stable transfection of clone #27 with a mer-Cre-mer (mCrem) expressing vector, cells from various clones were lysed and
50 mg of protein from each were run on an 8% SDS-PAGE gel. mCrem was visualized with polyclonal rabbit anti-Cre antibody (1:2000, Novagen), and
a highly expressing clone, 27Flip/Cre20 was selected for further study (red circle). D 27Flip and 27Flip/Cre20 cells were analyzed by flow cytometry, as
indicated. In contrast to the 27Flip parental line, the mCrem expressing 27Flip/Cre20 cells showed robust red fluorescence in a large subpopulation
despite the absence of the mer- ligand OHT.
doi:10.1371/journal.pone.0003264.g001
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with loss of NUDT9 expression. These results suggested that in
contrast to previous results, mCrem was capable of mediating
significant levels of constitutive recombination activity. Because such
unlicensed mCrem dependent recombination is a potential con-
founding factor for the reversible switching approach to conditional
gene inactivation, we set out to better characterize this phenomenon.
Sustained OHT-independent Cre activity in 27Flip/Cre20
cells correlates with mer-Cre-mer expression level
Several previous observations suggest that control of mCrem
recombination is less than perfect [11,20,26,27]. Based on these
observations, we were interested in clarifying the role of mCrem
expression level in OHT-independent recombination. We hypothe-
sized that low frequency OHT-independent recombination by
mCrem is mCrem intrinsic, and thus that OHT-independent Cre
activity should be demonstrable in other mCrem expressing clones,
and furthermore that as more mCrem would provide more activity,
the level of constitutive flipping should correlate with mCrem
expression level. To test this hypothesis, we re-transfected 27Flip cells
with the mCrem containing vector to generate a panel of 27Flip/Cre
clones expressing varying amounts of mCrem by western blot
(Fig. 3A). These clones were assigned to either ‘‘high’’ (27Flip/Cre15
and -20) or ‘‘low’’ (27Flip/Cre26, -31, and -35) mCrem expressing
categories and compared for flipping in the presence and absence of
1 mM OHT (Fig. 3B). Consistent with mCrem possessing intrinsic
OHT-independent recombination activity, clones with high expres-
sion showed OHT-independent Cre activity, while low expressing
clones exhibited little to no activity. Although the apparent decrease
in flipping for the high expressing clones at high OHT concentrations
suggested a potential difference in efficiency of recombination
depending on the orientation of the cassette, repeating these
experiments revealed variation in the size of the red population
ranging from 38–60% that changed from day to day (data not
shown), suggesting that background fluctuations in the population
occur in the context of constitutive ongoing flipping. Importantly, all
clones responded well to OHT treatment based on their establishing
a ,50:50 ratio of red to white cells over a 48 hour OHT treatment
(with a 50/50 ratio indicating flipping in ,100% of cells). Note that
clone 35, which at first glance appeared to have less red cells than
other clones, showed poorer separation of red and white populations
than other clones, making the percentage of white vs. red cells less
precise in this clone than others.
OHT-dependent mCrem activity saturates by 10 nM OHT
In a previous study [24] an OHT concentration of 50 nM was
used to induce mCrem mediated recombination, significantly
lower than the 1 mM used in the studies above. Thus, we wanted
to investigate the interaction between mCrem expression level and
OHT dose for induction of mCrem mediated recombination.
Thus, we treated both the high and low expressing 27Flip/Cre
clones with 100, 10, or 1 nM OHT for 48 hours, and compared
the treatment groups for Cre activity at 5 days after the start of
OHT treatment (Fig. 4). Since during OHT treatment the
construct spends equal time in the forward and reverse
orientations, all cells express mCherry during this time: as such,
we included a ‘‘rest’’ period of 3+ days to allow white cells to lose
any residual fluorescence. Clones 15 and 20 with constitutive
flipping activity exhibited only minor changes in population
distribution after OHT treatment - these minor changes may
reflect differing efficiencies of flipping in the forward and reverse
directions or differential effects of tamoxifen toxicity on the two
populations at the higher doses. Clones with lower mCrem
expression all exhibited dose dependent recombination, with the
clone with the lowest apparent mCrem expression (based on a
qualitative assessment of the western blot in Fig. 3A), 27Flip/
Cre31, showing the lowest level of activity at 1 nM Cre. This result
suggests that at sufficiently low OHT concentration, mCrem
expression level becomes limiting for recombination efficiency.
Nevertheless, although mCrem expression in this clone was near
the limit of detection in our western blot, we saw flipping in 100%
of cells at 10 nM OHT, suggesting that this concentration is
sufficient to maximize Cre activity when applied for 48 hours.
Consistent with previous work [11] we observed significant
mCrem mediated toxicity at 1 mM and 100 nM OHT, which
decreased at 10 nM and was essentially absent at 1 nM. In
Figure 2. Sustained OHT-independent flipping of the floxed cassette in 27Flip/Cre20 cells is a stable, ongoing process. mCherry (+)
and mCherry (2) 27Flip/Cre20 cells were separated by FACS and grown in culture for ,7 weeks. During this time period, a steady decrease in the
purity of the sorted populations was observed by flow cytometry. X-axis, mCherry fluorescence, Y-axis, cell number.
doi:10.1371/journal.pone.0003264.g002
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among high mCrem expressors as compared to low expressors at
100 and 10 nm OHT, plateauing at 1 mM and being undetectable
at 1 nM for all clones (data not shown).
Efficiency of OHT-dependent Cre activity correlates with
duration of OHT exposure
We noted that at all concentrations of OHT, the majority of
treated cells became positive for red fluorescence within 24 hours
(data not shown), suggesting that the majority of cells may already
have initiated switching well before the 48 hours of OHT
exposure typically employed by our and other labs [24]. We
therefore set out to identify the effect of varying OHT exposure
time in clones expressing different amounts of mCrem. We treated
the 27Flip/Cre clones with 1 nM OHT for 1, 2, 5, 10, and
24 hours before removing OHT and allowing the cells to grow for
five days in culture, at which point we examined the cells for red
fluorescence by FACS (Fig. 5A). In all clones except the high
expressor 27Flip/Cre15, a steady decline in recombination activity
was evident as OHT exposure time decreased: for 27Flip/Cre15
flipping was already at ,100% in the untreated population.
Coupled with the dose response of the various clones, these results
also provided further support for our conclusion from Fig. 3 that
recombination efficiency decreases with decreasing mCrem
expression. Flipping in 100% of the cells in all clones except
27Flip/Cre15 was not seen at exposure times less than 48 hours.
Surprisingly, we observed low level induction of Cre activity at
even 1 hour of 1 nM OHT exposure, a much shorter time than is
typically used for mCreminduction. Consequently wewerecurious if,
by using a high concentration of mCrem we might be able increase
the percentage of cells with Cre activity at early time points. Since we
showed that 100% of 27Flip/Cre31 cells underwent flipping at
10 nM applied for 48 hours (Fig. 4), we reasoned that a ten fold
excess of this saturating concentration would be sufficient to induce
rapid Cre activity. Thus we applied 100 nM OHT to 27Flip/Cre31
cells for short periods of time, allowed the cells to grow in culture for 5
days, and then analyzed flipping by FACS (Fig. 5B). Under these
conditions, we detected roughly50% of cellsundergoing flippingafter
4 hours of treatment with 100 nM OHT, and that roughly 1% of
cells had undergone flipping within just 10 minutes of OHT
treatment. These results suggest that although high concentration/
short time exposure of OHT can induce detectable recombination,
recombination does not occur with any degree of synchronicity in
DT40 cells, even within cells of a clonal population.
Discussion
Although some studies of the mCrem system [20,24,36] have
suggested that mCrem mediated recombination is tightly con-
Figure 3. Sustained OHT-independent flipping of the floxed cassette in 27Flip/Cre20 cells correlates with mer-Cre-mer expression
level. A Following stable transfection of 27Flip cells with an mCrem expressing vector, 5 clones expressing various amounts of mCrem were selected.
Cells from the clones were lysed and 50 mg of protein of each were run on an 8% SDS-PAGE gel. MCrem was visualized with polyclonal rabbit anti-Cre
antibody (1:2000, Novagen), with b-actin visualized with a polyclonal mouse antibody (1:40000, Sigma) as a loading control. 27Flip/Cre15 and -20
were designated ‘‘high expressors’’, and 27Flip/Cre26, -31, and -35 were designated ‘‘low expressors’’. B 27Flip/Cre clones were either left untreated or
treated with 1 mM OHT for 48 hours and then allowed to grow in culture for 18 days: all clones were subsequently analyzed by flow cytometry. The
27Flip parental cell line was used as a negative control.
doi:10.1371/journal.pone.0003264.g003
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with 1, 10, or 100 nM OHT for 48 hours and then allowed to grow in culture for 5 days from the onset of OHT treatment: subsequently all clones were
analyzed by flow cytometry. 27Flip parental cells were used as a negative control. X-axis, mCherry fluorescence, Y-axis, cell number.
doi:10.1371/journal.pone.0003264.g004
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ligand independent mCrem mediated recombination might occur,
albeit at low frequency [11,19,26,27]. This discrepancy has not
been systematically addressed to date in vitro or in vivo. This
prompted us to use a reversible switching system for analysis of the
parameters governing tamoxifen/OHT-regulated mCrem recom-
Figure 5. Efficiency of OHT-dependent flipping of the floxed cassette correlates with duration of OHT exposure in low mCrem
expressors. A 27Flip/Cre clones were either left untreated or treated with 1 nM OHT for 24, 10, 5, 2, or 1 hours, and then allowed to grow in culture
for 5 days: subsequently all clones were analyzed by flow cytometry. 27Flip parental cells were used as a negative control. B 27Flip/Cre31 cells were
either left untreated or treated with 100 nM OHT for 1, 2, 5, 10, 30, 60, 120, or 240 minutes and then allowed to grow in culture for 5 days:
subsequently all clones were analyzed by flow cytometry. X-axis, mCherry fluorescence, Y-axis, cell number.
doi:10.1371/journal.pone.0003264.g005
OHT-Regulated Recombination
PLoS ONE | www.plosone.org 6 September 2008 | Volume 3 | Issue 9 | e3264bination of a genomic target. In this report, we show that robust
mCrem expression correlates with a high level of tamoxifen/
OHT-independent Cre activity, while clones expressing mCrem at
the limit of western blot detection exhibit extremely tight
regulation. Additionally, we demonstrate that the Tamoxifen/
OHT dose response of clones varies with mCrem expression level.
In contrast to our results, it has been previously shown that in
DT40 cells expressing a reversible switching construct and
mCrem, little to no OHT-independent Cre activity occurred
[24]. These differences may be due to epigenetic differences at the
respective integration loci [37] or possibly the serendipitous use of
a low mCrem expressing clone (Cre expression levels were not
examined in those studies). Although it is difficult to predict or
control the former, our results clearly show that limiting mCrem
expression may be effective in controlling tamoxifen/OHT-
independent mCrem mediated recombination, although at the
expense of potentially requiring higher dose or duration of OHT
treatment to induce maximal recombination. Thus, future studies
using reversible switching should evaluate clones with a range of
low but detectable mCrem expression to identify those which
minimize unregulated mCrem activity but provide maximal
recombination at the desired OHT does and time of exposure.
Furthermore, it is important to monitor the stability of both the
forward and reverse populations in any reversible switching study
(particularly if an antibiotic resistance cassette is integrated in
either direction, since this may mask switching out of the given
orientation), for evidence of OHT-independent mCrem mediated
recombination. If unlicensed Cre activity is an issue, clones that
appear mCrem negative by western blot should be screened via
FACS with or without OHT treatment, since such clones may
express mCrem at levels low enough to be undetectable by western
blot but nevertheless be capable, as our results suggest, of
mediating mCrem dependent recombination.
Given that we observed tamoxifen/OHT-independent Cre
activity in several high expressing clones, we speculate that this
phenomenon is an intrinsic property of mCrem in DT40 cells,
possibly because of their small cytoplasmic volume, which may
encourage mCrem nuclear translocation as expression increases. It
is probably further generalizable that higher expression levels of
mCrem in any cell line or in vivo model will lead to a greater risk
for unlicensed activity: previous findings suggest that tamoxifen/
OHT-independent Cre activity also occurs in mice and murine
cells cultured in vitro [26,27]. Thus, our results suggest that
investigators should limit mCrem expression in any Cre-loxp
based model system where tight ligand-dependent regulation of
mCrem activity is crucial (our results in Figs. 3B, and 4 indicate
that even minimal expression of mCrem is sufficient for 100%
penetrance of Cre activity given an adequate OHT dose and time
of exposure).
Previous studies have examined the effects of tamoxifen/OHT
dosage on inducible Cre-mediated recombination, but never in the
context of variable Cre expression. Thus, our results provide
insight on tamoxifen/OHT dose and/or time of exposure
adjustments that must be made at varying Cre expression levels.
If low mCrem expressing clones are selected for study, as we
recommend above, investigators can expect that a sufficiently high
dose of OHT must be applied if 100% penetrance of
recombination is desired. Surprisingly, in our system a ‘‘sufficiently
high dose’’ titrated to only 10 nM OHT applied for 48 hours for
our lowest mCrem expressing clone, a dose 100 fold lower than
our standard OHT dose and 5 fold lower than the dose used in a
previous study [24]. Since work from our lab and others suggests
that mCrem mediated toxicity correlates with OHT dose, we
recommend the use of 10 nM OHT for 48 hours to maximize
penetrance while minimizing toxicity. This recommendation is
supported by our time course studies, since even in the highly
expressing clone 27Flip/Cre20, 1 nM OHT exposure times of
24 hours or less resulted in decreased Cre activity. Nevertheless,
exposure time and/or OHT dose can be adjusted considerably
depending on mCrem expression and the desired level of
penetrance. The finding that Cre activity is evident in some
27Flip/Cre31 cells within 10 minutes of high dose OHT (100 nM)
application, but that activity in 100% of cells cannot be achieved
within 4 hours was surprising, as it suggests that induction of
mCrem activity within even a clonal cell population is highly
asynchronous. Whether better synchronicity can be achieved by
examining only cells at a similar point in the cell cycle or by
applying toxic doses of ligand for short periods of time are
interesting areas for future investigation.
In conclusion, we show for the first time that robust mCrem
expression allows Cre activity independent of ligand binding, while
low mCrem expressing clones are largely free of this effect, and
that tamoxifen/OHT dose response correlates with changing
mCrem expression. Time and dose-dependent effects on mCrem
activity suggest limitations on the use of conditional targeting
approaches for applications which require tight temporal coordi-
nation of Cre action within a cell population.
Materials and Methods
Cell Culture
DT-40 B lymphocytes were cultured at 37uC with 5% CO2 in
RPMI 1640 Medium (Mediatech Inc.) supplemented with 10%
fetal bovine serum (FBS; Mediatech Inc.), 2% chicken serum
(Invitrogen), 10 units/ml penicillin/streptomycin (Mediatech Inc.),
2 mM glutamine (Mediatech Inc.) and beta mercaptoethanol
(50 mM; Sigma).
Molecular Biology
The ‘‘Flip’’ Construct backbone containing the loxp sites, 2
MCS sites, and the SV40 and BGH poly-A signals was synthesized
by DNA 2.0, Inc. Subsequently, the CMV promoter, chicken
NUDT9 cDNA, mCherry cDNA, and a B-actin-Neomycin
resistance cassette were inserted using various restriction sites.
The Left and Right homology arms extended from exon 4 to
exons 1 and 7 respectively. Integration of the Flip construct into
the NUDT9 locus was verified using the following primers, which
span the Neo-Right homology Arm and the Right homology arm-
genomic locus junctions in their product: Forward: ACA-
TAGCGTTGGCTACCCGTGATA, Reverse: ACTGCTTT-
GAAGGCCACACATTCC. The product of this PCR was also
sequenced following gel- or PCR purification. Following transfec-
tion, clones were selected in G418 (2 mg/mL, invitrogen), and
selected clones were screened for targeted integration via PCR.
Mer-Cre-mer, expressed in the pcDNA5T/O vector (invitro-
gen), was a generous gift from Michael Reth by way of Tomo
Kurosaki. Following transfection of mer-Cre-mer, clones were
selected in hygromycin (2 mg/mL, Calbiochem), and selected
clones were evaluated for mer-Cre-mer expression by western blot.
Clones were lysed and 50 mg of protein from each clone were run
on an 8% SDS-PAGE gel. Mer-Cre-mer was visualized using
polyclonal rabbit anti-Cre antibody (1:2000, Novagen, Inc.). b-
actin controls were stained with a mouse polyclonal anti-b actin
antibody (1:40,000, Sigma). The secondary antibody was perox-
idase conjugated donkey anti-rabbit from Amersham Pharmaceu-
ticals.
Stable tranfection of DT-40 B lymphocytes was carried out
using a Bio-Rad Gene-Pulser electroporation apparatus. Cells
OHT-Regulated Recombination
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7/0.5 ml serum-free medium) were pulsed in 0.4-cm
cuvettes with 50 mg plasmid DNA at 550 V and 25 mF.
Flow Cytometry
FACS analyses were performed on either a BD FACSAria
(Becton-Dickenson) or a BD LSRII (Becton-Dickenson), using a
green laser (561 nm) to excite the mCherry protein (excitation
max: 587 nm, emission max: 610 nm). Cells were resuspended in
media as described above, without the color indicator. 10,000
events were collected for each panel. Sorting experiments were
carried out on the BD FACSAria.
Cre induction
Cells expressing mer-Cre-mer were induced using 1 mM,
100 nM, 10 nM, or 1 nM 4-Hydroxytamoxifen (OHT) for 48,
24, 10, 5, 2, or 1 hour, or left untreated. Following tamoxifen
treatment, cells were centrifuged at 5006g for 5 minutes to collect
the cells, resuspended in 10 mL RPMI, and centrifuged again to
wash the cells. The cells were then resuspended in standard
medium and grown in culture for 3–50 days.
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